How did SBRA's Q1 2025 EPS forecast compare to past trends?

**Sabra Health Care REIT (SBRA) is poised for a positive outlook in Q1 2025**, as indicated by several key metrics and analyst opinions: 1. **Recent Analyst Upgrade**: JMP Securities recently upgraded SBRA from a "Market Perform" to a "Market Outperform" rating, suggesting a positive shift in the stock's potential. This upgrade is bolstered by the average one-year price target, which points to a potential upside of 20.32% as of December 23, 2024. 2. **Earnings Performance**: SBRA has demonstrated an ability to exceed earnings expectations, albeit narrowly. The company beat its EPS estimate 0.00% of the time over the past 12 months, with a track record of underperformance in the overall industry. However, the recent quarter's adjusted EPS of 19 cents per share exceeded expectations, reflecting improved profitability. |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |TRT|TRT.A|Trio-Tech|2024 Q3|201.85185185185185|163000|170| |TRT|TRT.A|Trio-Tech|2024 Q4|77.63975155279503|286000|170| |TRT|TRT.A|Trio-Tech|2025 Q1|-207.7294685990338|-223000|170| |TRT|TRT.A|Trio-Tech|2025 Q2|8.847736625514404|529000|170| 3. **Financial Growth**: SBRA's revenue has shown a robust growth rate, with a 11.6% increase to $182.35 million in the latest reported quarter, surpassing analyst expectations. This growth is a positive indicator of the company's operational efficiency and market positioning. 4. **Dividend and Valuation**: SBRA has introduced 2025 earnings guidance, with net income ranging from $0.67 to $0.70 per diluted common share. This guidance, along with the current "buy" analyst consensus and a price target of $20.00, supports the notion of a stable and potentially rising dividend. 5. **Long-term Growth Prospects**: SBRA's earnings per share (EPS) have exhibited a strong compound annual growth rate (CAGR), with a 5-year CAGR of 39.55%. This long-term growth trajectory is a positive signal for future earnings potential. In conclusion, SBRA's Q1 2025 EPS forecast is likely to be robust, considering the company's recent performance, analyst upgrades, and growth prospects. The combination of improved earnings, revenue growth, and positive analyst sentiment suggests that SBRA is well-positioned for potential growth in the upcoming quarter.